SciVision Biotech Inc. (TPE:1786)

Market Cap	5.06B -41.3%
Revenue (ttm)	890.43M +7.1%
Net Income	164.72M -23.7%
EPS	2.24 -23.4%
Shares Out	72.19M
PE Ratio	31.32
Forward PE	n/a
Dividend	3.25 (4.62%)
Ex-Dividend Date	Apr 25, 2025

Volume	119,977
Average Volume	375,830
Open	70.10
Previous Close	70.30
Day's Range	68.80 - 70.30
52-Week Range	67.40 - 129.50
Beta	0.51
RSI	38.28
Earnings Date	Mar 6, 2026

About SciVision Biotech

SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1990
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1786

Financial Performance

In 2025, SciVision Biotech's revenue was 886.62 million, an increase of 0.37% compared to the previous year's 883.31 million. Earnings were 162.34 million, a decrease of -32.99%.